Constant Therapeutics announced start of phase 2 trial of peptide drug TXA127 for COVID-19
On Jul. 29, 2020, Constant Therapeutics announced that its peptide drug TXA127, a pharmaceutical formulation of the natural…
On Jul. 29, 2020, Constant Therapeutics announced that its peptide drug TXA127, a pharmaceutical formulation of the natural…
On Jul. 29, 2020, Heat Biologics announced successful pre-clinical testing of the Company’s COVID-19 vaccine, which demonstrated in-vivo…
On Jul. 29, 2020, Quest Diagnostics announced that the FDA had granted emergency use authorization for a new…
On Jul. 29, 2020, Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA)…
On Jul. 28, 2020, the U.S. International Development Finance Corp. (DFC) announced that it had signed a letter…
On Jul. 28, 2020, scientists at the National Institute of Allergy and Infectious Diseases reported that two doses…
On Jul. 28, 2020, Apogenix announced that it had received regulatory approval to start a clinical phase II…
On Jul. 28, 2020, StartX, a non-profit startup community of more than 1600 Stanford faculty and alumni founders,…
On Jul. 28, 2020, Reata Pharmaceuticals announced that researchers at NYU Grossman School of Medicine (NYU) initiated an…
On Jul. 27, 2020, the NIH launched a $58 million initiative to advance data science, catalyze innovation and…
On Jul. 27, 2020, the Serum Institute of India announced that it was is conducting phase III clinical…
On Jul. 27, 2020, Emergent BioSolutions announced that it had signed an agreement to provide contract development and…
On Jul. 27, 2020, Albert Einstein College of Medicine announced that it had received a $9.5 million, five-year…
On Jul. 25, 2020, LabCorpᆴ announced it received an Emergency Use Authorization from the FDA permitting diagnostic testing…
On Jul. 23, 2020, kidney transplantation from deceased donors with HIV to people living with both HIV and…
On Jul. 23, 2020, the Centers for Disease Control and Prevention (CDC) released new science-based resources and tools…
On Jul. 23, 2020, Intravacc announced the publication of a study in Scientific Reports on alternatives to the…
On Jul. 22, 2020, a scientific analysis of more than 2,000 brain scans found evidence for highly reproducible…
On Jul. 22, 2020, the FDA announced the data analyzed in collaboration with Syapse revealed a stark reality…
On Jul. 22, 2020, University of California at Los Angeles researchers reported that they found. levels of antibodies…
On Jul. 22, 2020, Oragenics announced that the National Institutes of Health created stabilized pre-fusion spike protein (CoV-2…
On Jul. 22, 2020, Altimmune announced an agreement with Vigene Biosciences to manufacture AdCOVIDTM, Altimmuneメs single-dose intranasal vaccine…
On Jul. 22, 2020, Pfizer and BioNTech announced execution of an agreement with the U.S. Department of Health…
On Jul. 22, 2020, a new study led by Albert Einstein College of Medicine and Montefiore Health System…
On Jul. 21, 2020, PerkinElmer announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2…
On Jul. 21, 2020, GlaxoSmithKline and CureVac announced a strategic collaboration agreement for the research, development, manufacturing and…
On Jul. 21, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…
On Jul. 21, 2020, Bio-Techne announced that Exosome Diagnostics, a Bio-Techne brand, had completed validation testing for COVID-19…
On Jul. 20, 2020, AstraZeneca announced that Interim results from the ongoing Phase I/II COV001 trial, led by…
On Jul. 20, 2020, a scientific analysis of more than 2,000 brain scans found evidence for highly reproducible…